Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology
NCT07269314 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-12-08
Summary
The goal is to develop molecular systems to support or replace in microscopic characterization and in vitro tests with molecular biology systems capable of improving performance in parasitology tests. In particular, we will analyze the main pathogens: several Leishmania species (Old and New World Leishmania species), the five Plasmodium species of human interest (falciparum, oval, vivax, malariae and knowlesi) and Pneumocistys jiroveci, using molecular methods based on the speed, specificity and sensitivity necessary for their diagnosis. Furthermore, we want to provide specific elements for the typing of the species. Our aim is to improve diagnostic and specie classification methods by using PCR in microbiology and parasitology, to evaluate its impact on diagnosis. We would evaluate the impact of this method in terms of timing, sensitivity and specificity of diagnosis. We would also explore future possibilities on quantification techniques, in order to support the clinician to evaluate the efficacy of therapy during the follow-up.
Furthermore, we would evaluate these methods in terms of cost effectiveness towards classical direct methods, which are now operator-dependent.
Conditions
- Malaria, Pneumocystis, Leishmania
Sponsors & Collaborators
-
Fondazione IRCCS Policlinico San Matteo di Pavia
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2026-12-01
Countries
- Italy
Study Locations
More Related Trials
-
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
NCT02530697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment of Mucosal Bolivian Leishmaniasis
NCT04799236 ·Status: RECRUITING ·Phase: PHASE3
-
Comparison of Three Plasmodium Falciparum Isolates in an Experimental Human Malaria Infection
NCT01002833 ·Status: COMPLETED ·Phase: NA
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
Impact of Vaccines on Antimicrobial Microbial Resistance
NCT06450379 ·Status: COMPLETED
-
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
NCT00121823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults
NCT01624961 ·Status: COMPLETED ·Phase: PHASE1
-
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)
NCT02932072 ·Status: COMPLETED
-
Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
NCT01377974 ·Status: COMPLETED ·Phase: PHASE2
-
Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis
NCT01422954 ·Status: COMPLETED ·Phase: NA
-
Diagnosis and Treatment of Leishmania Infections
NCT00344188 ·Status: RECRUITING
-
French West Indies Leptospirosis Study
NCT01607047 ·Status: UNKNOWN
-
Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01218893 ·Status: COMPLETED ·Phase: NA
-
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
NCT06040489 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults
NCT02015091 ·Status: COMPLETED ·Phase: PHASE1
-
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
NCT00628719 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults
NCT06862453 ·Status: RECRUITING ·Phase: PHASE1
-
Plasmodium Falciparum Genomic Intelligence in Mozambique
NCT05306067 ·Status: COMPLETED
-
MMV533 Plasmodium Falciparum Volunteer Infection Study
NCT05205941 ·Status: COMPLETED ·Phase: PHASE1
-
Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults
NCT01771848 ·Status: COMPLETED ·Phase: PHASE1
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
NCT02639299 ·Status: RECRUITING
-
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
NCT06000514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
NCT03784248 ·Status: ACTIVE_NOT_RECRUITING
-
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
NCT00537953 ·Status: UNKNOWN ·Phase: PHASE2